Expanded Access Protocol for AL-Treatment Use of Neratinib for Adjuvant Breast Cancer

SUMMARY

N/A

COH Protocol Number : 15370

Principal Investigator : Bosserman, Linda M.D.

Sponsor : City of Hope

BRIEF ELIGIBILITY CRITERIA :

Eligible Ages : <=42;>=42

Gender : Female

Treatment Intent : Adjuvant treatment

Prior Chemotherapy :

Brain Metastases :

Measurable Disease :